Copper (Cu), capable of existing in various oxidation states, notably Cu(I) and Cu(II), plays a pivotal role in diverse biological redox reactions. This includes its involvement in pathways associated with oxidative stress in neurodegenerative disorders such as Alzheimer’s disease, Parkinson’s disease, and Transmissible Spongiform Encephalopathies.
This paper offers an overview of X‐ray Absorption Spectroscopy (XAS) studies designed to elucidate the interactions
between Cu ions and proteins or peptides associated with these neurodegenerative diseases. The emphasis lies on
the technique’s specificity, revealing the local coordination environment, and on its sensitivity to Cu oxidation states.
Furthermore, the paper focuses on XAS applications targeting the characterization of intermediate reaction states and explores the opportunities arising from recent advancements in time‐resolved XAS at ultra‐bright synchrotron and free
electron laser radiation sources.